Download PDF
1 / Pages

Other users also viewed these articles

Economic impact of the use of patiromer in chronic kidney disease or heart failure for the treatment of chronic hyperkalemia in Spain Patricia de Sequera; Ramón Bover; Yoana Ivanova-Markova; Alexandra Ivanova; Almudena González-Domínguez; Marta Valls; Verónica Campos;
Nefrologia (English Version). 2023;43:721-30
Consensus document on the management of hyperkalemia Alberto Ortiz; Carmen del Arco Galán; José Carlos Fernández-García; Jorge Gómez Cerezo; Rosa Ibán Ochoa; Julio Núñez; Francisco Pita Gutiérrez; Juan F. Navarro-González;
Nefrologia (English Version). 2023;43:765-82
Mineralcorticoid receptor blockers in chronic kidney disease Sara Erraez; Manuel López-Mesa; Pablo Gómez-Fernández;
Nefrologia (English Version). 2021;41:258-75